MDR1 polymorphisms associated with risk and survival in diffuse large B-cell lymphoma

By Hu Li-Li   Yu Bingyun   Yang Jine  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1188-1193

Informa Healthcare

Access to resources Recommend Favorite

Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis

By Yan Yulan   Liang Hongjie   Xie Li   He Yu   Li Meng   Li Ruolin   Li Shan   Qin Xue  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2191-2197

Springer Publishing Company

Access to resources Recommend Favorite

MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer

By Paule Bernard  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1066-1072

Humana Press, Inc

Access to resources Recommend Favorite

KT-5720 Reverses Multidrug Resistance in Variant S49 Mouse Lymphoma Cells Transduced With the Human MDR1 cDNA and in Human Multidrug-resistant Carcinoma Cells

By Galski H.   Lazarovici P.   Gottesman M.M.   Murakata C.   Matsuda Y.   Hochman J.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 380-388

Elsevier

Access to resources Recommend Favorite

MDR1 inhibition: less resistance or less relevance?

By Garraway L.A.   Chabner B.  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2337-2340

Elsevier

Access to resources Recommend Favorite